New hope for tough liver cancers: Nerve-Blocking technique added to standard therapy
NCT ID NCT07187284
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tests whether adding a nerve-blocking procedure (endovascular denervation) to standard treatments (TACE/HAIC and immune-targeted therapy) can help people with advanced liver cancer that has spread to the portal vein. The cancer must have gotten worse after initial treatment. About 62 adults will be randomly assigned to get the new combination or standard care alone. The goal is to see if the combination slows cancer growth in the liver and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Nanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.